Biotage AB Stock price

Equities

BIOT

SE0000454746

Advanced Medical Equipment & Technology

Real-time Estimate Cboe Europe 06:41:58 2024-03-19 am EDT 5-day change 1st Jan Change
174.2 SEK -0.63% Intraday chart for Biotage AB -5.03% +29.84%
Sales 2023 1.86B 178M Sales 2024 * 2.16B 207M Capitalization 14.14B 1.35B
Net income 2023 246M 23.54M Net income 2024 * 266M 25.46M EV / Sales 2023 5.61 x
Net cash position 2023 335M 32.06M Net cash position 2024 * 595M 56.95M EV / Sales 2024 * 6.27 x
P/E ratio 2023
40.2 x
P/E ratio 2024 *
53.1 x
Employees 674
Yield 2023
1.2%
Yield 2024 *
0.94%
Free-Float 99.55%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.45%
1 week-4.83%
Current month+0.92%
1 month-5.90%
3 months+43.10%
6 months+57.50%
Current year+31.11%
More quotes
1 week
174.00
Extreme 174
182.90
1 month
165.20
Extreme 165.2
185.60
Current year
122.20
Extreme 122.2
186.70
1 year
83.05
Extreme 83.05
186.70
3 years
83.05
Extreme 83.05
295.60
5 years
78.05
Extreme 78.05
295.60
10 years
9.80
Extreme 9.8
295.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 72 06-02-08
Director of Finance/CFO - 23-09-24
Chief Tech/Sci/R&D Officer 54 -
Members of the board TitleAgeSince
Chief Executive Officer 72 06-02-08
Director/Board Member 62 19-10-31
Chairman 61 Jan. 03
More insiders
Date Price Change Volume
24-03-19 173.6 -0.97% 8 465
24-03-18 175.3 -0.45% 67,240
24-03-15 176.1 -0.79% 67,991
24-03-14 177.5 -1.17% 86,814
24-03-13 179.6 -1.75% 45,286

Delayed Quote Nasdaq Stockholm, March 18, 2024 at 12:29 pm EDT

More quotes
Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The Company offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotage's offering within analytical chemistry consists of consumables with related applications to extract selected substances from various types of samples. The Company's offering within organic chemistry includes products for pharmaceutical development based on both small molecules and peptides and its offering within industrial resins is composed of polymer-based resins and research services that lead to the development and manufacture of polymer-based materials. As of December 31, 2013, the Company operated 12 wholly owned subsidiaries worldwide.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
175.3 SEK
Average target price
186.7 SEK
Spread / Average Target
+6.48%
Consensus
  1. Stock
  2. Equities
  3. Stock Biotage AB - Nasdaq Stockholm